Arkadios Wealth Advisors Has $2.91 Million Stock Holdings in Cigna Group $CI

Arkadios Wealth Advisors lessened its stake in Cigna Group (NYSE:CI) by 3.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,800 shares of the health services provider’s stock after selling 338 shares during the quarter. Arkadios Wealth Advisors’ holdings in Cigna Group were worth $2,909,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in CI. Valeo Financial Advisors LLC boosted its holdings in shares of Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Cigna Group in the 1st quarter valued at approximately $727,905,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after buying an additional 1,094,327 shares during the last quarter. GQG Partners LLC boosted its holdings in shares of Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after buying an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Cigna Group by 38.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after buying an additional 457,052 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Down 17.4%

CI opened at $247.11 on Friday. Cigna Group has a fifty-two week low of $245.61 and a fifty-two week high of $350.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a market capitalization of $65.96 billion, a P/E ratio of 13.49, a P/E/G ratio of 0.88 and a beta of 0.45. The stock has a fifty day moving average of $298.38 and a 200-day moving average of $306.70.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same quarter last year, the firm earned $7.51 earnings per share. The company’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.4%. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Insiders Place Their Bets

In related news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CI has been the subject of several recent analyst reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday, October 8th. Truist Financial set a $375.00 price target on Cigna Group in a report on Tuesday, September 2nd. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. Wells Fargo & Company raised their price target on Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a report on Tuesday, October 7th. Finally, Guggenheim reaffirmed a “buy” rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $369.89.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.